Real-world experience with an automated insulin delivery system

This trial is following nearly 1,900 people with type 1 diabetes who are using the iLet Bionic Pancreas, an automated insulin delivery device that helps manage blood sugar levels. The researchers want to understand how well this treatment works in real-world conditions and what kinds of problems or side effects people actually experience when using it at home. They'll compare the results to data from previous studies and registries to see how the iLet performs compared to other diabetes management approaches.

The iLet Bionic Pancreas is a newer technology, and while it has been tested in controlled clinical trials, the company needs to track how it performs when thousands of real patients use it in their daily lives. This study will help identify any unexpected issues and confirm that this treatment is safe and effective outside of a research setting.